Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03052569
Title Expanded Access to RXDX-105 for Cancers With RET Alterations
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Ignyta, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Additional content available in CKB BOOST